David Parada
Overview
Explore the profile of David Parada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
93
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Guma J, Pena K, Riu F, Guilarte C, Hernandez A, Lucia C, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497340
Liquid biopsy has improved significantly over the last decade and is attracting attention as a tool that can complement tissue biopsy to evaluate the genetic landscape of solid tumors. In...
12.
Pena K, Guma J, Guilarte C, Delamo L, Grifol M, Pique B, et al.
Front Biosci (Landmark Ed)
. 2022 Jul;
27(7):217.
PMID: 35866407
Background: SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is enveloped by four structural proteins. The entry of the virus into the host cells is mediated by spike protein binding...
13.
Pena K, Riu F, Hernandez A, Guilarte C, Badia J, Parada D
J Clin Med
. 2022 Jul;
11(13).
PMID: 35807141
Urothelial bladder cancer is a heterogeneous disease and one of the most common cancers worldwide. Bladder cancer ranges from low-grade tumors that recur and require long-term invasive surveillance to high-grade...
14.
Daubisse-Marliac L, Grosclaude P, Carulla M, Parada D, Vilardell L, Ameijide A, et al.
Int J Environ Res Public Health
. 2022 Mar;
19(5).
PMID: 35270406
Due to the differences in the definition, criteria of inclusion and coding of urothelial tumours (UTs), data of different cancer registries (CRs) are not comparable. The aim of this work...
15.
Pena K, Riu F, Guma J, Guilarte C, Pique B, Hernandez A, et al.
Pathogens
. 2021 Jul;
10(7).
PMID: 34201967
The pandemic caused by the SARS-CoV-2 infection affects many aspects of public health knowledge, science, and practice around the world. Several studies have shown that SARS-CoV-2 RNA in plasma seems...
16.
Pena K, Kepa A, Cochs A, Riu F, Parada D, Guma J
Genes (Basel)
. 2021 Jan;
12(1).
PMID: 33435629
Although sentinel lymph node biopsy (SLNB) has proved to be able to diagnose axillary lymph node status safely and reliably, there is still not enough evidence to suggest that it...
17.
Parada D, Pena K, Guma J, Guilarte C, Riu F
Histopathology
. 2020 Sep;
78(4):586-592.
PMID: 32970870
Introduction: We describe cytologic and immunohistologic findings in virus transport medium on cases under investigation of SARS-CoV-2 infection. Methods: Cytologic findings in cases under investigation of SARS-CoV-2 infection from one...
18.
Henriquez Lopez I, Parada D, Gallardo P, Gascon M, Besora A, Pena K, et al.
Rep Pract Oncol Radiother
. 2017 May;
22(3):251-257.
PMID: 28479874
Objectives: Ki-67 is a proliferation marker in prostate cancer. A prognostic RNA signature was developed to characterize prostate cancer aggressiveness. The aim was to evaluate prognostic correlation of CCP and...
19.
Parada D, Pena K, Riu F, Aguilar A, Cohan S
Mol Clin Oncol
. 2016 Nov;
5(5):507-510.
PMID: 27882235
Sentinel lymph node biopsy (SLNB) is an accurate, safe method for determining the axillary lymph node status. However, insufficient evidence exists to support the recommendation of SLNB in patients who...
20.
Rubio-Casadevall J, Borras J, Carmona-Garcia M, Ameijide A, Gonzalez-Vidal A, Ortiz M, et al.
World J Surg Oncol
. 2015 Apr;
13:47.
PMID: 25885906
Background: Gastrointestinal stromal tumors are sarcomas of the digestive tract characterized by mutations mainly located in the c-KIT or in the platelet-derived growth factor receptor (PDGFR)-alpha genes. Mutations in the...